Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, August 28, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Royal Philips’ acquisition of Intact Vascular, Inc. for $360 million. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’s unique, specialized implantable device to optimize the treatment of patients with Peripheral... Read More »
QIAGEN Pushes On After Thermo Fisher Walks Away
In early March, Thermo Fisher Scientific Inc. (NYSE: TMO) announced a takeover QIAGEN N.V. (NYSE: QGEN) for $11.5 billion, or $43.64 per share in cash. The offer seemed high enough, as the target company only generated revenues of $1.53 billion in 2019, but the COVID-19 pandemic complicated the deal. QIAGEN saw a surge in product demand used in COVID-19 testing, as net sales grew 16% in Q2:20 over the same quarter in 2019, so its shareholders thought Thermo Fisher’s needed to up its offer. Thermo Fisher revised its offer to $49 per share on August 4, but it needed a minimum acceptance threshold of 66.67% from QIAGEN shareholders before the August 10 deadline. The new acquisition... Read More »
Vocera Adds New Patient Engagement Firm
Vocera Communications, Inc. (NYSE: VCRA), a mobile technology company serving the healthcare market, has expanded its patient engagement platform through a new acquisition. Last week, Vocera purchased a 100% interest in EASE Applications, LLC for $25 million in cash. This is Vocera’s first acquisition of 2020, but the company has had a solid financial year, reporting total revenue of $47.3 million for the second quarter of 2020, compared to revenue of $44.8 million in the second quarter of 2019. Its remote communication services were probably in high demand due to changes triggered by COVID-19. The addition of EASE will most likely help them in the COVID-19 environment as well. EASE... Read More »
JNJ Announces Multibillion-Dollar Takeover of Momenta
Johnson & Johnson (NYSE: JNJ) made a splash in the healthcare M&A market last week with its acquisition of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA). The global pharmaceutical giant announced on August 19 it is paying $6.5 billion in cash, or $52.50 per share, for Momenta, a 70.4% premium over Momenta’s August 18 closing price. Momenta reported a trailing 12-month revenue of $30.07 million. On the day of the announcement, Momenta’s share price jumped 69%. This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of JNJ to broaden its market reach in immune-mediated diseases and drive further growth through expansion into autoantibody-driven... Read More »
Health Care M&A Deals, August 21, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Johnson & Johnson’s $6.5 billion acquisition of Momenta Pharmaceuticals, Inc., which provides an opportunity for JNJ to broaden its portfolio in immune-mediated diseases and autoantibody-driven diseases. To subscribe to our Health Care M&A deals chart and more, visit our membership... Read More »
Pinnacle Treatment Centers Adds HealthQwest
Pinnacle Treatment Centers and Linden Capital Partners, L.P. began their partnership in 2016, launching a national behavioral health platform in the years since. When Pinnacle Treatment Centers was acquired by Linden Capital, it served roughly 10,000 patients daily at approximately 30 facilities, according to Deal Search Online. In 2020, the company treats 31,000 patients daily in California, Indiana, Kentucky, New Jersey, Ohio, Pennsylvania and Virginia, with over 115 community-based locations. The company has grown organically, opening new locations and facilities, but also through acquisitions with the backing of Linden Capital. In April 2019, Pinnacle acquired three outpatient opioid... Read More »
Health Care M&A Deals, August 14, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Bayer AG’s $425 million acquisition of KaNDy Therapeutics Ltd., which will give Bayer KaNDy’s NT-814, a potentially first in class receptor antagonist which showed positive findings for the treatment of moderate to severe vasomotor symptoms due to menopause. To subscribe to our Health Care M&A deals chart and more,... Read More »
MOB Deals Accelerate in the Third Quarter
Medical office building (MOB) transactions have been flowing steadily throughout the third quarter, with 11 deals on the books so far according to DSO. Most deals are focused on facilities in the Southeastern region of the United States, such as Alabama, North and South Carolina, and Georgia, and the buyers are a mix of REITs, private real estate investment firms, and developers. So far in the third quarter, over 376,000 square feet of MOBs have been sold, with disclosed prices totaling approximately $113.6 million. Unlike other sectors in healthcare, MOBs seem to have benefited from a COVID-19 environment, as noted by JLL ( NYSE: JLL) in a report published in July. The COVID-19 pandemic... Read More »
Health Catalyst Acquires Vitalware
Health Catalyst (NASDAQ: HCAT) has been an active buyer this year. In July, the digital health firm purchased healthfinch, Inc. for $40 million to build its population health portfolio and electronic health record platform, and now it is boosting its revenue cycle management services. Health Catalyst announced last week it is acquiring Vitalware, LLC, which provides revenue workflow optimization and analytics SaaS technology solutions to healthcare organizations. The terms of the deal include $120 million upfront and an additional $30 million could be paid as a potential earnout. The upfront payment will be comprised of a mix of cash and 1,487,210 shares valued at $33.62. Vitalware offers... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
